LBT INNOVATIONS LIMITED - Announcements

Market Cap $21.47M Add to my watchlist

Healthcare Medical Devices

LBT Innovations is a ground-breaking designer of advanced technology solutions for the... LBT Innovations is a ground-breaking designer of advanced technology solutions for the medical industry. We specialise in combining artificial intelligence, image analysis and software engineering to improve healthcare delivery. Our product, APAS® Independence, is a global first solution for automated reading of microbiology culture plates.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

LBT	Notice of initial substantial holder		20/11/23	164.04KB	Share
LBT	Application for quotation of securities - LBT		20/11/23	29.08KB	Share
LBT	Placement Completes Financial Restructure	PRICE SENSITIVE	20/11/23	132.13KB	Share
LBT	Top 20 Option Holders		15/11/23	130.11KB	Share
LBT	Application for quotation of securities - LBT		15/11/23	29.25KB	Share
LBT	Renounceable Rights Issue Results	PRICE SENSITIVE	15/11/23	119.95KB	Share
LBT	$1.7M SA Government Loan Restructure	PRICE SENSITIVE	06/11/23	148.64KB	Share
LBT	Entitlement Offer Underwriting Increased to $3.6M	PRICE SENSITIVE	27/10/23	81.08KB	Share
LBT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	26/10/23	385.09KB	Share
LBT	Proposed issue of securities - LBT		25/10/23	24.9KB	Share
LBT	Notice of Annual General Meeting/Proxy Form		25/10/23	705.98KB	Share
LBT	Entitlement Offer Letters Mailed to Shareholders		23/10/23	457.81KB	Share
LBT	Investor Call - Entitlement Offer		13/10/23	108.43KB	Share
LBT	Proposed issue of securities - LBT		13/10/23	39.96KB	Share
LBT	Prospectus	PRICE SENSITIVE	13/10/23	788.16KB	Share
LBT	$4.5 million Entitlement Offer	PRICE SENSITIVE	13/10/23	148.04KB	Share
LBT	Full Repayment of $1.38M Share Placement Facility	PRICE SENSITIVE	13/10/23	114.6KB	Share
LBT	APAS PharmaQC Exhibited at Pharmaceutical Conference		05/10/23	243.03KB	Share
LBT	Annual Report		29/09/23	3.97MB	Share
LBT	Appendix 4G		29/09/23	286.43KB	Share
LBT	Corporate Governance Statement		29/09/23	265.65KB	Share
LBT	Application for quotation of securities - LBT		11/09/23	24.86KB	Share
LBT	LBT RECEIVES $848,673 R&D TAX INCENTIVE		05/09/23	96.07KB	Share
LBT	Notice under Section 708A - Cleansing Notice		04/09/23	86.02KB	Share
LBT	Application for quotation of securities - LBT		01/09/23	24.98KB	Share
LBT	Preliminary Annual Financial Report & Appendix 4E	PRICE SENSITIVE	31/08/23	899.3KB	Share
LBT	Proposed issue of securities - LBT		29/08/23	24.75KB	Share
LBT	Proposed issue of securities - LBT		29/08/23	25.01KB	Share
LBT	Application for quotation of securities - LBT		21/08/23	24.83KB	Share
LBT	First APAS PharmaQC Performance Data		10/08/23	470.64KB	Share
LBT	Notice under Section 708A - Cleansing Notice		07/08/23	86.24KB	Share
LBT	Non-Cash Impairment of Intangible Assets	PRICE SENSITIVE	04/08/23	116.2KB	Share
LBT	Application for quotation of securities - LBT		31/07/23	24.99KB	Share
LBT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	26/07/23	351.93KB	Share
LBT	Notification of cessation of securities - LBT		12/07/23	21.7KB	Share
LBT	Notification of cessation of securities - LBT		10/07/23	21.78KB	Share
LBT	Final Directors Interest Notice		05/07/23	184.05KB	Share
LBT	Initial Directors Interest Notice		05/07/23	138.93KB	Share
LBT	Proposed issue of securities - LBT		05/07/23	26.63KB	Share
LBT	Chairman Appointment/Resignation		03/07/23	118.7KB	Share
LBT	APAS Presented at ASM Conference		20/06/23	131.44KB	Share
LBT	APAS Compact Extension to Project Funding Timeframe		20/06/23	116.59KB	Share
LBT	Notice under Section 708A - Cleansing Notice		02/06/23	86.08KB	Share
LBT	Application for quotation of securities - LBT		02/06/23	24.98KB	Share
LBT	Notice under Section 708A - Cleansing Notice		26/05/23	86.34KB	Share
LBT	Application for quotation of securities - LBT		26/05/23	24.96KB	Share
LBT	New Company Presentation		12/05/23	1.59MB	Share
LBT	Upcoming Investor Webinar Presentation		10/05/23	102.78KB	Share
LBT	LBT Board - Chair Transition Process		08/05/23	107.09KB	Share
LBT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/04/23	365.77KB	Share
LBT	NEW APAS-AMR DATA PRESENTED AT GLOBAL CONFERENCE		19/04/23	243.91KB	Share
LBT	Notification of cessation of securities - LBT		11/04/23	21.69KB	Share
LBT	Director Retirement & Appendix 3Z		30/03/23	253.29KB	Share
LBT	Notice under Section 708A - Cleansing Notice		23/03/23	86.52KB	Share
LBT	Notification regarding unquoted securities - LBT		23/03/23	27.84KB	Share
LBT	Application for quotation of securities - LBT		23/03/23	25.37KB	Share
LBT	Proposed issue of securities - LBT		20/03/23	29.73KB	Share
LBT	Placement Supports APAS Pharma & EU Expansion	PRICE SENSITIVE	20/03/23	174.43KB	Share
LBT	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/23	1.17MB	Share
LBT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	23/01/23	463.53KB	Share
LBT	LBT Company Presentation		20/01/23	1.03MB	Share
LBT	Quarterly Investor Call		19/01/23	106.85KB	Share
LBT	Notification of cessation of securities - LBT		11/01/23	21.71KB	Share
LBT	AstraZeneca Partners LBT for APAS Pharma Development	PRICE SENSITIVE	09/01/23	117.2KB	Share
LBT	Release from Escrow		03/01/23	86.54KB	Share
LBT	LBT Strengthens APAS Pharma Development	PRICE SENSITIVE	20/12/22	110.44KB	Share
LBT	CCS Appoint Thermo Fisher as Exclusive European Distributor	PRICE SENSITIVE	19/12/22	115.88KB	Share
LBT	Appendix 3Y - all Directors		02/12/22	268.2KB	Share
LBT	Notice under s708A - Cleansing Notice		28/11/22	86.3KB	Share
LBT	Notification regarding unquoted securities - LBT		28/11/22	23.99KB	Share
LBT	Application for quotation of securities - LBT		28/11/22	24.92KB	Share
LBT	Non-renounceable Rights Issue Results	PRICE SENSITIVE	28/11/22	114.71KB	Share
LBT	Application for quotation of securities - LBT		25/11/22	24.83KB	Share
LBT	Entitlement Offer Letters Mailed to Shareholders		01/11/22	346.05KB	Share
LBT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/10/22	456.94KB	Share
LBT	Application for quotation of securities - LBT		31/10/22	25.02KB	Share
LBT	Application for quotation of securities - LBT		26/10/22	24.88KB	Share
LBT	Proposed issue of securities - LBT		26/10/22	24.76KB	Share
LBT	Results of Meeting		26/10/22	154.28KB	Share
LBT	Chair's Address to Shareholders		26/10/22	155.46KB	Share
LBT	CEO Presentation		26/10/22	994.52KB	Share
LBT	LBT Receives $1,206,058 R&D Tax Incentive		25/10/22	134.71KB	Share
LBT	Proposed issue of securities - LBT		25/10/22	33.28KB	Share
LBT	Rights Issue Prospectus	PRICE SENSITIVE	25/10/22	630.34KB	Share
LBT	Non-Renounceable Rights Issue	PRICE SENSITIVE	25/10/22	198.85KB	Share
LBT	$1.5M Funding Awarded for New APAS Instrument	PRICE SENSITIVE	24/10/22	207.89KB	Share
LBT	Notification of cessation of securities - LBT		17/10/22	22.22KB	Share
LBT	Notice of Annual General Meeting/Proxy Form		21/09/22	619.17KB	Share
LBT	BioPhorum Presentation		14/09/22	2.32MB	Share
LBT	APAS Independence Market Update		13/09/22	132.28KB	Share
LBT	Company Presentation ASX Small and Mid-Cap Conference		13/09/22	1020.52KB	Share
LBT	New Data Published on APAS Technology		31/08/22	128.29KB	Share
LBT	Appendix 4G		29/08/22	272.99KB	Share
LBT	Corporate Governance Statement		29/08/22	274.9KB	Share
LBT	Annual Report to shareholders		29/08/22	2.88MB	Share
LBT	Appendix 4E	PRICE SENSITIVE	29/08/22	126.33KB	Share
LBT	Application for quotation of securities - LBT		24/08/22	27.24KB	Share
LBT	Proposed issue of securities - LBT		16/08/22	25.34KB	Share
LBT	Updated Product Pipeline Strategy Announced		10/08/22	440.9KB	Share
LBT	Notification of cessation of securities - LBT		03/08/22	21.64KB	Share

LBT Notice of initial substantial holder
20/11/23		164.04KB	Share
LBT Application for quotation of securities - LBT
20/11/23		29.08KB	Share
LBT Placement Completes Financial Restructure
20/11/23	PRICE SENSITIVE	132.13KB	Share
LBT Top 20 Option Holders
15/11/23		130.11KB	Share
LBT Application for quotation of securities - LBT
15/11/23		29.25KB	Share
LBT Renounceable Rights Issue Results
15/11/23	PRICE SENSITIVE	119.95KB	Share
LBT $1.7M SA Government Loan Restructure
06/11/23	PRICE SENSITIVE	148.64KB	Share
LBT Entitlement Offer Underwriting Increased to $3.6M
27/10/23	PRICE SENSITIVE	81.08KB	Share
LBT Quarterly Activities/Appendix 4C Cash Flow Report
26/10/23	PRICE SENSITIVE	385.09KB	Share
LBT Proposed issue of securities - LBT
25/10/23		24.9KB	Share
LBT Notice of Annual General Meeting/Proxy Form
25/10/23		705.98KB	Share
LBT Entitlement Offer Letters Mailed to Shareholders
23/10/23		457.81KB	Share
LBT Investor Call - Entitlement Offer
13/10/23		108.43KB	Share
LBT Proposed issue of securities - LBT
13/10/23		39.96KB	Share
LBT Prospectus
13/10/23	PRICE SENSITIVE	788.16KB	Share
LBT $4.5 million Entitlement Offer
13/10/23	PRICE SENSITIVE	148.04KB	Share
LBT Full Repayment of $1.38M Share Placement Facility
13/10/23	PRICE SENSITIVE	114.6KB	Share
LBT APAS PharmaQC Exhibited at Pharmaceutical Conference
05/10/23		243.03KB	Share
LBT Annual Report
29/09/23		3.97MB	Share
LBT Appendix 4G
29/09/23		286.43KB	Share
LBT Corporate Governance Statement
29/09/23		265.65KB	Share
LBT Application for quotation of securities - LBT
11/09/23		24.86KB	Share
LBT LBT RECEIVES $848,673 R&D TAX INCENTIVE
05/09/23		96.07KB	Share
LBT Notice under Section 708A - Cleansing Notice
04/09/23		86.02KB	Share
LBT Application for quotation of securities - LBT
01/09/23		24.98KB	Share
LBT Preliminary Annual Financial Report & Appendix 4E
31/08/23	PRICE SENSITIVE	899.3KB	Share
LBT Proposed issue of securities - LBT
29/08/23		24.75KB	Share
LBT Proposed issue of securities - LBT
29/08/23		25.01KB	Share
LBT Application for quotation of securities - LBT
21/08/23		24.83KB	Share
LBT First APAS PharmaQC Performance Data
10/08/23		470.64KB	Share
LBT Notice under Section 708A - Cleansing Notice
07/08/23		86.24KB	Share
LBT Non-Cash Impairment of Intangible Assets
04/08/23	PRICE SENSITIVE	116.2KB	Share
LBT Application for quotation of securities - LBT
31/07/23		24.99KB	Share
LBT Quarterly Activities/Appendix 4C Cash Flow Report
26/07/23	PRICE SENSITIVE	351.93KB	Share
LBT Notification of cessation of securities - LBT
12/07/23		21.7KB	Share
LBT Notification of cessation of securities - LBT
10/07/23		21.78KB	Share
LBT Final Directors Interest Notice
05/07/23		184.05KB	Share
LBT Initial Directors Interest Notice
05/07/23		138.93KB	Share
LBT Proposed issue of securities - LBT
05/07/23		26.63KB	Share
LBT Chairman Appointment/Resignation
03/07/23		118.7KB	Share
LBT APAS Presented at ASM Conference
20/06/23		131.44KB	Share
LBT APAS Compact Extension to Project Funding Timeframe
20/06/23		116.59KB	Share
LBT Notice under Section 708A - Cleansing Notice
02/06/23		86.08KB	Share
LBT Application for quotation of securities - LBT
02/06/23		24.98KB	Share
LBT Notice under Section 708A - Cleansing Notice
26/05/23		86.34KB	Share
LBT Application for quotation of securities - LBT
26/05/23		24.96KB	Share
LBT New Company Presentation
12/05/23		1.59MB	Share
LBT Upcoming Investor Webinar Presentation
10/05/23		102.78KB	Share
LBT LBT Board - Chair Transition Process
08/05/23		107.09KB	Share
LBT Quarterly Activities/Appendix 4C Cash Flow Report
28/04/23	PRICE SENSITIVE	365.77KB	Share
LBT NEW APAS-AMR DATA PRESENTED AT GLOBAL CONFERENCE
19/04/23		243.91KB	Share
LBT Notification of cessation of securities - LBT
11/04/23		21.69KB	Share
LBT Director Retirement & Appendix 3Z
30/03/23		253.29KB	Share
LBT Notice under Section 708A - Cleansing Notice
23/03/23		86.52KB	Share
LBT Notification regarding unquoted securities - LBT
23/03/23		27.84KB	Share
LBT Application for quotation of securities - LBT
23/03/23		25.37KB	Share
LBT Proposed issue of securities - LBT
20/03/23		29.73KB	Share
LBT Placement Supports APAS Pharma & EU Expansion
20/03/23	PRICE SENSITIVE	174.43KB	Share
LBT Half Yearly Report and Accounts
28/02/23	PRICE SENSITIVE	1.17MB	Share
LBT Quarterly Activities/Appendix 4C Cash Flow Report
23/01/23	PRICE SENSITIVE	463.53KB	Share
LBT LBT Company Presentation
20/01/23		1.03MB	Share
LBT Quarterly Investor Call
19/01/23		106.85KB	Share
LBT Notification of cessation of securities - LBT
11/01/23		21.71KB	Share
LBT AstraZeneca Partners LBT for APAS Pharma Development
09/01/23	PRICE SENSITIVE	117.2KB	Share
LBT Release from Escrow
03/01/23		86.54KB	Share
LBT LBT Strengthens APAS Pharma Development
20/12/22	PRICE SENSITIVE	110.44KB	Share
LBT CCS Appoint Thermo Fisher as Exclusive European Distributor
19/12/22	PRICE SENSITIVE	115.88KB	Share
LBT Appendix 3Y - all Directors
02/12/22		268.2KB	Share
LBT Notice under s708A - Cleansing Notice
28/11/22		86.3KB	Share
LBT Notification regarding unquoted securities - LBT
28/11/22		23.99KB	Share
LBT Application for quotation of securities - LBT
28/11/22		24.92KB	Share
LBT Non-renounceable Rights Issue Results
28/11/22	PRICE SENSITIVE	114.71KB	Share
LBT Application for quotation of securities - LBT
25/11/22		24.83KB	Share
LBT Entitlement Offer Letters Mailed to Shareholders
01/11/22		346.05KB	Share
LBT Quarterly Activities/Appendix 4C Cash Flow Report
31/10/22	PRICE SENSITIVE	456.94KB	Share
LBT Application for quotation of securities - LBT
31/10/22		25.02KB	Share
LBT Application for quotation of securities - LBT
26/10/22		24.88KB	Share
LBT Proposed issue of securities - LBT
26/10/22		24.76KB	Share
LBT Results of Meeting
26/10/22		154.28KB	Share
LBT Chair's Address to Shareholders
26/10/22		155.46KB	Share
LBT CEO Presentation
26/10/22		994.52KB	Share
LBT LBT Receives $1,206,058 R&D Tax Incentive
25/10/22		134.71KB	Share
LBT Proposed issue of securities - LBT
25/10/22		33.28KB	Share
LBT Rights Issue Prospectus
25/10/22	PRICE SENSITIVE	630.34KB	Share
LBT Non-Renounceable Rights Issue
25/10/22	PRICE SENSITIVE	198.85KB	Share
LBT $1.5M Funding Awarded for New APAS Instrument
24/10/22	PRICE SENSITIVE	207.89KB	Share
LBT Notification of cessation of securities - LBT
17/10/22		22.22KB	Share
LBT Notice of Annual General Meeting/Proxy Form
21/09/22		619.17KB	Share
LBT BioPhorum Presentation
14/09/22		2.32MB	Share
LBT APAS Independence Market Update
13/09/22		132.28KB	Share
LBT Company Presentation ASX Small and Mid-Cap Conference
13/09/22		1020.52KB	Share
LBT New Data Published on APAS Technology
31/08/22		128.29KB	Share
LBT Appendix 4G
29/08/22		272.99KB	Share
LBT Corporate Governance Statement
29/08/22		274.9KB	Share
LBT Annual Report to shareholders
29/08/22		2.88MB	Share
LBT Appendix 4E
29/08/22	PRICE SENSITIVE	126.33KB	Share
LBT Application for quotation of securities - LBT
24/08/22		27.24KB	Share
LBT Proposed issue of securities - LBT
16/08/22		25.34KB	Share
LBT Updated Product Pipeline Strategy Announced
10/08/22		440.9KB	Share
LBT Notification of cessation of securities - LBT
03/08/22		21.64KB	Share

REFRESH

First 2 3 4 5 6

(20min delay)
Last 1.3¢		Change -0.001(7.14%)		Mkt cap ! $21.47M

Open	High	Low	Value	Volume
1.4¢	1.4¢	1.3¢	$12.8K	950K

Buyers (Bids)

No.	Vol.	Price($)
6	4268596	1.3¢

Sellers (Offers)

Price($)	Vol.	No.
1.4¢	197886	2

View Market Depth

No.	Vol.	Price($)
5	4245520	0.013
3	7333332	0.012
6	806500	0.011
5	1089004	0.010
3	256759	0.009

Price($)	Vol.	No.
0.015	429699	3
0.016	931586	6
0.017	990881	7
0.018	457000	3
0.020	115000	1

Last trade - 14.43pm 20/09/2024 (20 minute delay)


Last 1.3¢		Change -0.001 ( 3.70 %)
Open	High	Low	Volume
1.5¢	1.5¢	1.3¢	662691
Last updated 15.59pm 20/09/2024 ?

LBT (ASX) Chart

LBT INNOVATIONS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available